Print

Biogen Idec Announces Webcast Of Analyst Discussion At American Society of Hematology (ASH) 
10/19/2005 5:09:26 PM

CAMBRIDGE, Mass. and SAN DIEGO, Calif., Dec. 5 /PRNewswire-FirstCall/ -- Biogen Idec Inc. announced today that its analyst discussion of Biogen Idec related abstracts at the American Society of Hematology (ASH) will be webcast live on Saturday, December 6, 2003. The live webcast begins at 10:00 am (ET) and is accessible through Biogen Idec's website, http://www.biogenidec.com/.

(Logo: http://www.newscom.com/cgi-bin/prnh/20031112/LAW121LOGO ) About Biogen Idec

Biogen Idec creates new standards of care in oncology and immunology. As a global leader in the development, manufacturing, and commercialization of novel therapies, Biogen IDEC transforms scientific discoveries into advances in human healthcare. For product labeling, press releases and additional information about the company, please visit http://www.biogenidec.com/.

Contact: Rob Jacobson Investor Relations Specialist Biogen Idec Inc. Rob.Jacobson@BiogenIdec.com 617/679-3710

Photo: http://www.newscom.com/cgi-bin/prnh/20031112/LAW121LOGOAP Archive: http://photoarchive.ap.org/PRN Photo Desk, 888-776-6555 or 212-782-2840 Biogen Idec Inc.

CONTACT: Rob Jacobson, Investor Relations Specialist of Biogen IdecInc., +1-617-679-3710, Rob.Jacobson@BiogenIdec.com


//-->